Long-acting therapeutic delivery systems for the treatment of gliomas
S Padmakumar, MM Amiji - Advanced Drug Delivery Reviews, 2023 - Elsevier
Despite the emergence of cutting-edge therapeutic strategies and tremendous progress in
research, a complete cure of glioma remains elusive. The heterogenous nature of tumor …
research, a complete cure of glioma remains elusive. The heterogenous nature of tumor …
Current developments in targeted drug delivery systems for glioma
Background: Glioma is one of the most commonly observed tumours, representing about
75% of brain tumours in the adult population. Generally, glioma treatment includes surgical …
75% of brain tumours in the adult population. Generally, glioma treatment includes surgical …
Frontiers in the treatment of glioblastoma: Past, present and emerging
Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive
research over the last several decades, the survival rates for GBM have not improved and …
research over the last several decades, the survival rates for GBM have not improved and …
Insights into multifunctional nanoparticle-based drug delivery systems for glioblastoma treatment
Glioblastoma (GB) is an aggressive cancer with high microvascular proliferation, resulting in
accelerated invasion and diffused infiltration into the surrounding brain tissues with very low …
accelerated invasion and diffused infiltration into the surrounding brain tissues with very low …
Injectable local drug delivery systems for glioblastoma: a systematic review and meta-analysis of progress to date
Y Wang, C Bastiancich, B Newland - Biomaterials Science, 2023 - pubs.rsc.org
Glioblastoma (GBM) is an aggressive malignant cancer associated with bleak prognosis and
high mortality. The current standard of care for GBM is maximum surgical resection plus …
high mortality. The current standard of care for GBM is maximum surgical resection plus …
Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors
Malignant brain tumors including glioblastoma are incurable cancers. Over the last years a
number of promising novel treatment approaches have been investigated including the …
number of promising novel treatment approaches have been investigated including the …
[HTML][HTML] Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?
Despite all recent advances in malignant glioma research, only modest progress has been
achieved in improving patient prognosis and quality of life. Such a clinical scenario …
achieved in improving patient prognosis and quality of life. Such a clinical scenario …
[HTML][HTML] Molecular targets and nanoparticulate systems designed for the improved therapeutic intervention in glioblastoma multiforme
Glioblastoma multiforme (GBM) is the most aggressive and fatal CNS related tumors, which
is responsible for about 4% of cancer-related deaths. Current GBM therapy includes surgery …
is responsible for about 4% of cancer-related deaths. Current GBM therapy includes surgery …
Advances in drug delivery technology for the treatment of glioblastoma multiforme
Glioblastoma multiforme (GBM) is a particularly aggressive and malignant type of brain
tumor, notorious for its high recurrence rate and low survival rate. The treatment of GBM is …
tumor, notorious for its high recurrence rate and low survival rate. The treatment of GBM is …
Localized drug delivery systems in high‐grade glioma therapy—from construction to application
M Hauck, D Hellmold, C Kubelt… - Advanced …, 2022 - Wiley Online Library
High‐grade gliomas are the most common and most malign primary brain tumors. Current
therapy approaches only reach unsatisfactory results, still not providing a long‐lasting time …
therapy approaches only reach unsatisfactory results, still not providing a long‐lasting time …